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Abstract
Background: From a health services perspective, peer-based resources merit special attention. Participation in self-
help fellowships, like the Twelve Step Groups (TSGs), have been shown to improve outcomes of patients with
substance use disorder (SUD) and they represent a valuable adjunct to the SUD treatment system. This study
investigated the relationship between patient perceptions of TSGs and the intent to participate in TSGs after
receiving detoxification treatment.
Methods: We included 139 patients that entered a detoxification unit (detox) in Kristiansand, Norway. We analyzed
factors associated with the intention to participate in TSGs post-discharge with contingency tables and ordinal
regression analysis.
Results: Forty-eight percent of patients had participated in TSGs before entering detox. Respondents saw more
advantages than disadvantages in TSG participation, but only 40% of patients showed high intentions of
participating in TSGs post-discharge. A high intention to participate in TSGs was most strongly correlated with the
notion that participation in TSGs could instill the courage to change. In a multivariate analysis, the perception that
TSGs were beneficial was the strongest factor related to a high intention of TSG participation after treatment.
Conclusions: Our findings increased the understanding of factors most likely to influence decisions to attend TSGs
in SUD treatment contexts with uncommon TSG participation. Our results suggested that the majority of patients
may be sufficiently influenced by highlighting the potential gains of TSG participation. Treatment programs that do
not focus on self-help group attendance during and after treatment should consider implementing facilitative
measures to enhance utilization of these fellowships.
Background
Publicly funded health services are currently exposed to
increasing fiscal constraints, and this may cause a reduc-
tion in service [1]. To remain abreast with ever increas-
ing demands, one option for treatment services might
be to consider greater involvement with voluntary ser-
vices, like peer-based groups. This strategy is also
recommended by the World Health Organization
(WHO) [2,3]. Patients with substance use disorder
(SUD) have the option to participate in addiction-
focused, mutual-help groups, like the Twelve Step
Groups (TSGs) of Alcoholics Anonymous (AA) or Nar-
cotics Anonymous (NA). Participation in TSGs has been
shown to improve success rates after treatment and
TSGs are considered a valuable adjunct to formal SUD
treatment [4-6]. These groups are valued as an impor-
tant recovery resource in their country of origin, the
United States. Accordingly, engagement strategies, most
notably the Twelve Step Facilitation (TSF) initiative,
have been developed for clinicians to introduce the 12-
step principles to patients [7]. The prevalence of lifetime
TSG attendance in the target population of patients
with SUD is generally high in the U.S.; three studies
reported that 66%, 78%, and 83% of patients had pre-
viously had at least some involvement at treatment arri-
val [8-10]. High levels have also been noted in the
intention to participate in TSGs; in a recent U.S.-based
study, 79% of patients planned to attend AA or NA at
least twice a week after treatment [11]. Two United
Kingdom studies reported similar pre-treatment atten-
dance levels, with 73% and 77% of patients that had had
at least some previous participation [12,13]. However, * Correspondence: john-kare.vederhus@sshf.no
1Addiction Unit, Sørlandet Hospital HF, Kristiansand, Norway
Full list of author information is available at the end of the article
Vederhus et al. BMC Health Services Research 2011, 11:339
http://www.biomedcentral.com/1472-6963/11/339
© 2011 Vederhus et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.only 47% had intended to attend TSG meetings regu-
larly following discharge [12].
In other European countries, studies on patient per-
ceptions of TSGs are scarce. A few studies have investi-
gated clinician attitudes and knowledge about TSGs;
those findings suggested that clinicians were relatively
unaware of these fellowships, and referrals were uncom-
mon [14,15]. Hence, there is a need for developing stra-
tegies that enhance TSG utilization in areas that have
little awareness of TSG programs. The first step is to
examine substance users’ experiences with and percep-
tions of existing 12-step fellowships.
Factors Associated with TSG Participation
In early U.S.-based studies, the patient perceived severity
of a SUD problem was the most reliable predictor of
subsequent TSG participation [16,17]. Other demo-
graphic, personality, social, cognitive, or substance-
related variables were weakly or inconsistently asso-
ciated with participation [16]. The Survey of Readiness
for AA Participation (SYRAAP) [18,19] indicated that
there were three primary influential factors; the per-
ceived severity of the SUD problem, the perceived bene-
fits of TSGs, and the perceived barriers to TSG
participation. These factors predicted TSG affiliation
better than demographic or life context factors [19].
The SYRAAP may also be used to examine patient per-
ceptions of TSGs. In the present analysis, we used beha-
vioral intention as the dependent variable. This indexed
ap e r s o n ’s motivation to perform a particular behavior
(here, to attend TSGs); it also indicated both the direc-
tion (i.e., yes/no) and intensity of a decision to engage
in a behavior (e.g., the degree of effort a person is pre-
pared to expend) [20].
Objectives
The aims of this paper were: (1) Explore patient percep-
tions of the benefits and barriers of TSGs at admission
to a detoxification unit (detox), and (2) investigate the
relationship between patient perceptions of TSGs and




Patients were recruited from a detox unit in the Addic-
tion Unit, Sørlandet Hospital in Kristiansand, Norway
from September 2008 to August 2010. The main service
area for this institution was the most southern county
in Norway (population 166, 000). Eligible patients had
an alcohol or drug use disorder, did not receive opioid
maintenance treatment, remained in the detox unit suf-
ficiently long for assessment, were discharged to their
homes, and had access to at least one TSG within 30
km of their home. Exclusion criteria were severe psy-
chiatric co-morbidity and an inability to complete a
structured interview (due to, for example, severe somatic
symptoms, cognitive disability, or language problems).
Of the 156 eligible patients, 16 refused to participate
and one provided insufficient data. The final sample
included 139 patients (89% of eligible respondents).
After providing informed consent, participants com-
pleted the inventory described below. The Regional
Ethics Committee of the South-East Health Region,
Norway, approved the study.
Measures
The Addiction Severity Index, European version (Euro-
pASI), was used to collect data on patient demographics,
life context, substance use, and treatment history
[21,22]. The Mini International Neuropsychiatric Inter-
view (MINI), version 5.0, was used to assess a SUD
diagnosis [23]. Any pre-detox TSG affiliation was
assessed with the AA Affiliation Scale (AAAS) [24]. The
wording was modified to include both AA and NA. The
frequency of attendance to 12-step meetings during
one’s lifetime and during the prior 6 months was coded
with a 0 to 1 scale (e.g., the lifetime scale was: 0.25 = 1-
30 meetings, 0.5 = 31-90 meetings, 0.75 = 91-500, and 1
= > 500 meetings). In addition, seven yes/no involve-
ment items (e.g., read TSG literature, had a sponsor)
were coded from 0 (no, never) to 1 (yes). The translated
version of the AAAS had similar good internal consis-
tency as the original scale (Cronbach’s a = 0.81). The
total TSG attendance and involvement scores resulted
in a composite score that ranged from 0 to 9.
The Survey of Readiness for AA Participation (SYRAAP)
measured the patients’ perceived severity of the substance
problem and the patients’ perceptions of the relevance of
TSGs to their problem. These were measured with the
perceived benefits and perceived barriers items [19]. The
wording was modified to include both AA and NA.
Questions were rated in a 5-point Likert-type response
format, where higher scores indicated higher levels of the
construct under assessment. The Norwegian version had
good internal consistency with Cronbach’s a values
between 0.75 and 0.85 for the three subscales [25]. To
further confirm the psychometric properties of the scale
after translation, a principal axis factor analysis was per-
formed showing that the translated version had the same
structure as the original version and all items had satis-
factory factor loadings (> 0.4) within their respective sub-
scales [26]. A mean score was computed for each sub-
scale (5 questions in each subscale).
The Intent to attend AA/NA was rated with two ques-
tions on a 7-point Likert scale: “I intend to attend AA/
NA meetings regularly (at least twice a month) over the
next six months” and “I will attend AA/NA meetings
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months” [27]. The two items were highly correlated (r =
.98), and a composite score was computed by averaging
them. For descriptive and analytic purposes, scale
responses were categorized into low (< 3), moderate (3 -
5), and high (> 5) intentions.
The original English questionnaires (AAAS and SYR-
A A P )w e r et r a n s l a t e dt oN o r w e g i a nw i t has t a n d a r d
procedure (two forward and two backward translations)
[28], in collaboration with the questionnaire developers.
Statistical analyses
For all variables, descriptive statistics were computed. The
two translated scales were checked for reliability with
Cronbach’s a [25]. To examine the underlying factor
structure of the SYRAAP, a principal axis factor analysis
(with Promax rotation) was performed and compared with
the original instrument [26]. In contingency tables, we
used single items from the SYRAAP’s benefits and barriers
subscales to maximize information about these potentially
modifiable constructs; the gamma measure of association
was used to explore the strength of association between
variables. Contingency table analysis and Chi-square or
non-parametric tests (Kruskal-Wallis) were used to
explore associations between the intention to participate
in TSGs and independent variables. Finally, a multivariate
ordinal regression analysis was performed; results were
expressed as odd ratios (OR) and 95% confidence intervals
(CI). Age, gender, and variables with p values < 0.2 in the
bivariate analyses were included in the multivariate analy-
sis [29]. The significance level was set at p < 0.05. All sta-
tistical analyses were performed with SPSS 16.0.
Results
Sample description
We studied 139 patients (Table 1), with a mean age of
41 years. One-third of the patients were women, almost
all were native Norwegians or European-born, and
about half were living alone. The majority of patients
(77%) had had some kind of specialized SUD treatment
previously, and nearly all had been diagnosed with alco-
hol and/or drug dependence (6 of the patients who were
diagnosed with an alcohol use disorder only met the cri-
teria for harmful use). Forty-eight percent of patients
had previously participated in a TSG at least once. The
mean AAAS composite score (TSG involvement) was
1.7 (out of a maximum of 9). The curve was highly posi-
tively skewed; 59% of respondents scored ≤1( i . e . ,t h e y
did not respond “yes” to any involvement items).
Perceived benefits and barriers associated with TSG
participation
The two most frequently recognized benefits of partici-
pating in TSGs were “In AA/NA, I will find people who
understand me” (78%), and “I fIg ot oA A / N A ,Iw i l l
find people who can guide me in how to be sober”
(73%) (Table 2). Between 55% and 78% of patients
agreed with each of the five statements that described
the potential benefits of TSGs; this suggested that the
majority of patients thought that TSGs were a potential
option for obtaining help and support with combating
addiction. The two barrier statements most frequently
recognized regarded embarrassment; first, they were
embarrassed to go to AA/NA (37%), and second, they
did not want other people to know that s/he was going
to AA/NA (29%) (Table 2).
Intention to participate in TSGs post-detox
The intention to participate regularly in TSGs during
the 6 months following detox was low for 43 (31%)
patients (score < 3), moderate for 41(29%) patients
(score = 3-5), and high for 55 (40%) patients (score > 5).
Patient perceptions associated with intention to
participate in TSGs
There was a clear trend that patients that perceived
more benefits and fewer barriers also had higher inten-
tions to participate in TSGs post discharge (Table 2).
However, those with high and moderate intentions also
seemed to put some weight on embarrassment in going
Table 1 Characteristics of study respondents (N = 139)
Characteristic N (%), or
Mean
(SD)
Age, years 41 (14)
Female 45 (32%)
Proportion native Norwegians or European origin 134
(96%)
Education, years 11.2 (2.3)
Relationship, proportion of singles 65 (47%)
Main diagnosis (ICD-10)
Alcohol dependence (N = 48) or harmful use of alcohol
(N = 6)
54 (39%)
Both alcohol and drug dependence 26 (19%)
Drug dependence 59 (42%)
Years of problematic use
a, major drug/s of abuse 11.4 (9.1)
Earlier treatment (prior to current detox)
No earlier treatment 32 (23%)
Outpatient treatment only 33 (24%)
Inpatient treatment
12-step-based treatment 39 (28%)
Other inpatient treatment (detox or longer-term) 35 (25%)
Ever participated in TSGs before 66 (48%)
Earlier involvement in TSGs (AAAS composite score; scale 0 -
9)
1.7 (2.4)
a Problematic use, as defined in EuropASI, was the consumption of 5 or more
standard drinks at least 3 times weekly, or binge drinking on 2 coherent days
to a level that afflicted daily functioning
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strongest positive correlations were found in the con-
structs “Going to AA gives me courage to change”
(gamma = 0.79, p < 0.001) and “If I go to AA/NA, I will
find people who can guide me in how to be sober”
(gamma = 0.78, p < 0.001). The strongest negative cor-
relation was found for “If e e ll i k eId on o tb e l o n ga t
AA/NA meetings” (gamma = - 0.65, p < 0.001; Table 2).
Independent variables associated with Intention to
participate in TSGs
Associations were analyzed between the mean values
and proportions of independent variables and the
intention to participate in TSGs after treatment (Table
3). The results indicated that women were more polar-
ized than men in their intention to participate in TSGs.
The TSG involvement scores (Table 3) and attendance
rates (35%, 34%, and 67% in the ‘low’, ‘moderate’ and
‘high’ intention groups, respectively) indicated that
patients with the highest prior attendance/involvement
were the most inclined to re-enter the groups. The
three SYRAAP subscales showed that patients with high
perceived severity, high perceptions of benefits, and low
perceptions of barriers had significantly higher inten-
tions to participate in TSGs compared to the other
patients. All three groups (high, moderate, and low















Going to AA/NA gives me courage to change (N = 138) Disagree 11 0 0 11 (8)
N/N 24 19 6 49 (36) 0.79
Agree 8 22 48 78 (57)
If I go to AA/NA, I will find people who can guide me in how to be sober (N = 135) Disagree 8 1 0 9 (7)
N/N 18 9 0 27 (20) 0.78
Agree 16 31 52 99 (73)
I will feel better about myself if I go to AA/NA (N = 139) Disagree 16 1 2 19 (14)
N/N 21 17 6 44 (32) 0.71
Agree 6 23 47 76 (55)
In AA/NA, I will find people who understand me (N = 138) Disagree 3 0 2 5 (4)
N/N 18 6 1 25 (18) 0.62
Agree 21 35 52 108 (78)
I know someone who has been helped by going to AA/NA (N = 138) Disagree 19 10 5 34 (25)
N/N 6 9 3 18 (13) 0.51
Agree 18 22 46 86 (62)
Perceived barriers
I feel like I do not belong at AA/NA meetings (N = 139) Disagree 8 18 42 68 (49)
N/N 15 21 9 45 (32) - 0.65
Agree 20 2 4 26 (19)
Going to AA/NA makes me feel depressed (N = 138) Disagree 11 27 44 82 (59)
N/N 19 11 10 40 (29) - 0.62
Agree 12 3 1 16 (12)
I do not want people to know that I am going to AA/NA (N = 139) Disagree 10 22 37 69 (50)
N/N 10 11 9 30 (22) - 0.43
Agree 23 8 9 40 (29)
Going to AA/NA requires changes that are too difficult (N = 139) Disagree 9 14 33 56 (40)
N/N 19 20 13 52 (37) - 0.41
Agree 15 7 9 31 (22)
Going to AA/NA can be embarrassing to me (N = 139) Disagree 9 21 32 62 (45)
N/N 12 6 7 25 (18) - 0.36
Agree 22 14 16 52 (37)
a For descriptive purposes, the original scale has been coded pooling strongly agree and agree responses, and the strongly disagree and disagree responses. N/N
= neither disagreed nor agreed
b LOW, Low score < 3; MOD, intermediate score = 3 - 5; HIGH, high score > 5, on a 7-point Likert scale
c Gamma-values were obtained from an analysis of the full ordinal scale for independent variables. All items were significant at the p < 0.001 level.
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TSG benefit subscale; i.e., more agreed than disagreed
with the benefit items. The perceptions of benefits dif-
fered among groups only in strength. On the perceived
barriers subscale, the mean scores for the low intention
group was on the agreement side of the scale (i.e., more
agreed than disagreed with barrier items); in contrast,
both the moderate and high intention groups had mean
scores on the disagreement side (i.e., more disagreed
than agreed with barrier items). These findings sug-
gested that there was a qualitative difference between
the low versus the moderate and high intention groups
in the perception of TSG barriers. Thus, the barriers
were a problem primarily in the low intention group.
No other factors, including age, relationship status, edu-
cational status, or diagnosis had significant influence on
the intention to participate in TSGs. However, in con-
trast to patients with lower intentions, those with higher
intentions tended to be older and to have an alcohol use
disorder diagnosis (Table 3).
Only two variables were retained in the multivariate
analysis; the perceived barriers, which were negatively
associated, and the perceived benefits, which were posi-
tively associated with high intentions to participate in
TSGs after treatment (Table 4). The strongest influential
factor was the perception that TSGs were beneficial (OR
4.74, 95% CI = 2.34 - 9.63, p < 0.001).
Discussion
This study found that less than half of the participating
patients that entered the detox program in this Norwe-
gian addiction treatment unit had previously attended
TSGs. Nevertheless, three-quarters of patients agreed
with the benefit items on the questionnaire. This
implied an understanding that TSGs were a potential
supportive resource. However, only 40% of patients
reported a high intention to participate in TSGs after
discharge. The constructs most strongly correlated with
a high intention to participate in TSGs after detox were
the notions that participation in TSGs could instill the
courage to change and that TSGs could provide absti-
nence-specific support. The strongest predictor of a low
intention to participate was the sense of not belonging
in AA/NA. Between-group comparisons based on cate-
gorizations of low, moderate, and high intentions indi-
cated that perceived barriers was a problem primarily in
the low intention group. An ordinal regression model
showed that the recognition of TSG benefits was the
strongest influence on the intention to participate in
TSGs after treatment.












Gender (female) 19 (44%) 7 (17%) 19 (35%) 0.027
Age, years 40 (14) 38 (13) 44 (13) 0.081
Relationship, % single 23 (54%) 19 (46%) 23 (42%) 0.516
Education, years 11 (2) 11 (2) 12 (3) 0.481
Main diagnosis
Alcohol use disorder 13 (30%) 15 (37%) 25 (46%)
Both alcohol and drug use disorder 7 (16%) 5 (12%) 14 (26%) 0.088
Drug use disorder 23 (54%) 21 (51%) 16 (29%)
Perceived drug problem severity (SYRAAP subscale) 3.9 (0.7) 4.2 (0.6) 4.3 (0.6) 0.012
Perceived benefits of TSGs (SYRAAP subscale) 3.1 (0.8) 3.7 (0.5) 4.3 (0.6) < 0.001
Perceived barriers of TSGs (SYRAAP subscale) 3.3 (0.8) 2.6 (0.8) 2.2 (0.6) < 0.001
Earlier involvement in TSGs (AAAS composite score) 0.8 (1.7) 0.9 (1.6) 3.0 (2.9) < 0.001
Data are the mean (SD) and N (%), N = 139.
a LOW, Low score < 3; MOD, intermediate score = 3 - 5; HIGH, high score > 5, on a 7-point Likert scale
b P-value was obtained with a Kruskal-Wallis or Chi-square test
Table 4 Multivariate ordinal regression analysis of
associations between the intention to participate in TSGs
after detox treatment versus independent variables (N =
139)
Independent variables OR 95% CI P- value
Gender (women) 1.36 0.67 - 2.75 0.394
Age 0.98 0.95 - 1.02 0.274
Main diagnosis
Drug dependence (reference) -
Both alcohol and drug dependence 1.30 0.50 - 3.40 0.595
Alcohol use disorder 2.68 0.97 - 7.41 0.058
Earlier involvement in TSGs
(AAAS composite score)
1.13 0.96 - 1.34 0.142
Perceived drug problem severity 1.40 0.81 - 2.50 0.218
Perceived barriers towards TSGs 0.54 0.32 - 0.91 0.021
Perceived benefits of TSGs 4.74 2.34 - 9.63 < 0.001
Results are adjusted odd ratios (OR) and 95% confidence intervals (CI); age,
gender and variables with p < 0.2 in bivariate analyses (Table 3) were
included in the multivariate analysis.
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TSGs prior to admittance at the detox unit. This pro-
portion was substantially lower than the 66% to 83%
reported in previous U.S. and U.K.-based studies
[8-10,12,13] and also lower than the 60% observed in a
Swedish treatment study [30]. An even smaller propor-
tion reported some involvement with these fellowships;
o n l y4 1 %h a da tl e a s to n ep o s i t i v er e s p o n s et ot h eT S G
involvement questionnaire items. The twelve-step based
treatment models usually require patients to begin TSG
attendance during treatment [31]. This study was con-
ducted in a Norwegian county that offered a 12-step-
oriented treatment unit; however, 12-step based treat-
ment units are quite rare in Norway; they comprise less
than 5% of the available treatment programs [32].
Therefore, lower TSG attendance rates could be
expected in most other Norwegian counties. Thus, the
present findings indicate that the TSG attendance rate
in Norway is lower than that found in other European
countries, including the U.K., and neighboring Sweden.
Despite the fact that a majority (52%) of patients had
no prior TSG experience, a substantially larger propor-
tion of patients agreed with the TSG benefit items than
with the TSG barrier items. This suggested that percep-
tions of TSGs tended to be more positive than negative,
and that TSGs were perceived as potential supportive
resources. Although this Norwegian sample had less
prior experience with TSGs than that observed in a U.
S.-based patient sample (48% versus 66% had ever
attended AA/NA) [9], a large proportion of the Norwe-
gians (roughly three-quarters of respondents) recognized
the benefits frequently cited by U.S. patients, including
support and fellowship from peers and help with sobri-
ety and recovery. An important mechanism in peer sup-
port groups is the sense of identification with other
attendees. This feature may be appreciated even more
than the support obtained from professionals [33].
Almost three-quarters of patients also agreed that TSGs
were a possible resource for obtaining abstinence-speci-
fic support. Although being drug free is not required for
attending TSGs, these fellowships are strongly absti-
nence-oriented [34]. Our patients seemed to perceive
both that they needed support in achieving abstinence
and that TSGs offered a structure that may facilitate the
achievement of that goal.
The intention to participate in TSGs was most
strongly correlated with the notion that participation in
TSGs could instill the courage to change. Addiction
researchers have underscored the chronic nature of
SUDs [35]. Thus, patients have negative perceptions of
coping with triggers and urges and are likely to experi-
ence relapses. Although the negative consequences of
addiction may steer people towards making changes,
hope and courage may be required before abstinence
becomes a realistic alternative. Thus, identifying with
role models that have learned to manage their addiction
represents a positive adjunct to the support provided by
professionals [36,37].
The most important negative predictor for intending
to participate in TSGs was “I feel like I do not belong at
TSG meetings”. There are at least two reasons for agree-
ing with this item. The individual may have attended a
TSG previously and decided that “this is not the right
place for me”. Another possibility is that they had not
been to a TSG previously, or they had attended just a
f e wm e e t i n g s ,b u td i dn o ts t a yl o n ge n o u g ht og a i na
sense of belonging to the group. To get involved with a
new social group, one has to get past the difficult
threshold of attending the first meeting, and persevere
long enough to become accustomed to the new setting.
Tonigan, Connors, and Miller (2003) highlighted the
importance of initiating TSG attendance during formal
treatment of individuals with addictions [38]. The
Matching Alcoholism Treatments to Client Heterogene-
i t y( M A T C H )p r o j e c tc o m p a r e dp a t i e n t st h a tw e r e / w e r e
not involved in TSGs during treatment. Those not
involved during treatment had much less TSG participa-
tion after treatment. Thus, a 12-step facilitation initiative
that encouraged patients to attend TSGs during treat-
ment appeared to contribute significantly to patient par-
ticipation rates post discharge [38].
One of the barriers recognized by those with high
intentions to participate in TSGs was embarrassment
about going to AA/NA. This may reflect the difficulty
that many patients have in disclosing a problem with
alcohol and drugs. For those that had attended pre-
viously, there may also be emotional and psychological
obstacles related to rejoining a group after a relapse
[31]. Thus, patients may require extra support and
encouragement to attend a TSG when they are ambiva-
lent about rejoining a group.
Forty percent of patients reported a high intention to
participate in TSGs after discharge; 31% had a low
intention; and 29% had a moderate intention. These
findings were consistent with those of a U.K.-based
study by Harris et al., who reported a similar distribu-
tion; roughly one-third of the sample fell into each cate-
gory of “negative”, “neutral”,o r“positive” attitudes
toward TSGs [13]. Those authors noted that the pre-
sence of a considerably sized, non-polarized/neutral
group challenged their preconception that substance
users were heavily polarized in their attitudes towards
TSGs [13]. These “neutral” individuals are likely to be
moved towards a greater intention to participate when
addiction professionals highlight the potential gains of
participation and recommend participation. The present
study supported these notions; our results indicated that
the perceived barriers towards TSGs were a problem
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from professionals may enhance patient perceptions of
the relevance of TSGs to their problems; moreover, the
clinician’s approval of TSGs may be an important path-
way towards recovery [39]. The importance of enhan-
cing the perception of TSG benefits was also implied by
our regression analysis, which demonstrated a strong
association between a high perception of benefits and a
high intention to participate in TSGs.
Methodological considerations
This study was among the few European studies to
examine patient perceptions of TSGs. The study had a
number of strengths that included a focus on comple-
mentary peer-based resources for a population that had
no or few continuing care appointments in the formal
treatment system although they were likely to need sup-
port over lengthy intervals. Standardized instruments
were used. The original English questionnaires (AAAS
and SYRAAP) underwent a formal translation procedure
to provide a level of quality for the validity of the ques-
tionnaire content [28]. The psychometric properties of
the translated scales were satisfactory. Although slightly
older (41 versus 38 years), the present sample was simi-
lar to the detox patients (N = 564) of a previous regio-
nal multisite study [40]; they exhibited similar gender,
ethnicity, major substance of abuse, and previous SUD
treatment. We have no reason to believe that the health
region in this study differs from other regions in Nor-
way. Thus, the findings of the present study were gener-
alizable to other detox patients in Norway.
This study also had limitations, particularly in inter-
preting the findings. We used a cross-sectional design
that did not allow the establishment of cause among the
variables. In addition, the dependent variable in the ana-
lysis was a psychological construct (behavioral intention)
known to predict behavior, but we had not established
to what degree patients actually follow their intentions.
However, an intention is regarded as the most immedi-
ate and important predictor of subsequent behavior
[20]. Although we measured perceptions of TSGs with a
standardized instrument, it was developed in a different
cultural setting and the list of single items most relevant
for the perceived benefits/barriers constructs may not
be exhaustive in the present culture.
Implications
The findings of this study have increased the under-
standing of the beliefs likely to influence the patient’s
decision to attend TSGs after SUD treatment in con-
texts where TSG attendance and involvement are not
routine. These modifiable perceptions may be targeted
by clinicians to promote patient readiness to participate
in TSGs. Treatment programs not accustomed to
putting a focus on self-help group attendance during
and after treatment should consider implementing facili-
tative measures. For example, members of AA/NA
could be invited to treatment units to acquaint patients
with the groups.
Conclusions
Overall, our findings suggested that a majority of
patients could potentially be motivated to attend TSGs
with a relatively simple strategy. The primary strategy
should be to highlight the potential gains of participa-
tion. Those hesitant in joining the TSGs should be
encouraged to explore potential barriers that give rise to
scepticism towards TSGs. Acquainting patients with
TSGs may reduce perceived barriers and enhance utili-
zation of these voluntary fellowships. Patients with no
or little continuing care in the formal services should be
made aware of these informal, accessible recovery
resources.
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